These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 187099)

  • 1. Immunotherapy with nonviable microbial components.
    Ribi E; Milner KC; Granger DL; Kelly MT; Yamamoto K; Brehmer W; Parker R; Smith RF; Strain SM
    Ann N Y Acad Sci; 1976; 277(00):228-38. PubMed ID: 187099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor regression caused by endotoxins and mycobacterial fractions.
    Ribi EE; Granger DL; Milner KC; Strain SM
    J Natl Cancer Inst; 1975 Nov; 55(5):1253-7. PubMed ID: 173865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
    Meyer TJ; Ribi EE; Azuma I; Zbar B
    J Natl Cancer Inst; 1974 Jan; 52(1):103-11. PubMed ID: 4359409
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy of cancer: tumor suppression and regression by cell walls of Mycobacterium phlei attached to oil droplets.
    Gray GR; Ribi E; Granger D; Parker R; Azuma I; Yamamoto K
    J Natl Cancer Inst; 1975 Sep; 55(3):727-30. PubMed ID: 1159851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of guinea pig cancer with BCG.
    Zbar B; Rapp HJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
    Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ
    J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6'-dimycolate).
    Bekierkunst A
    Int J Cancer; 1975 Sep; 16(3):442-7. PubMed ID: 170221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.
    Yarkoni E; Rapp HJ
    Infect Immun; 1980 Jun; 28(3):887-92. PubMed ID: 6995326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma.
    Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ
    J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

  • 11. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs.
    McLaughlin CA; Cantrell JL; Ribi E; Goldberg EP
    Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
    Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
    Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration.
    Yarkoni E; Meltzer MS; Rapp HJ
    Int J Cancer; 1977 Jun; 19(6):818-21. PubMed ID: 326683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
    Wainberg MA; Deutsch V; Weiss DW
    Br J Cancer; 1976 Nov; 34(5):500-8. PubMed ID: 187207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
    Boyle MD; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
    McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
    Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.
    Yarkoni E; Rapp HJ
    Infect Immun; 1980 Jun; 28(3):881-6. PubMed ID: 6995325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
    Yarkoni E; Rapp HJ
    Oncology; 1982; 39(5):314-8. PubMed ID: 7099513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.
    Zbar B; Rapp HJ; Ribi EE
    J Natl Cancer Inst; 1972 Mar; 48(3):831-5. PubMed ID: 4333775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.